The nuclear factor kappa‐light‐chain‐enhancer of activated B cell (NF‐κB) p50/p65 heterodimer is the oncogenic transcription factor driving the expression of oncogenes and plays the critical mediator role in tumour progression. This evidence concerns the gene NFKB1 and neoplasm.